In this study, we focused on the upregulated lncRNAs because of their possible use as therapeutic targets or prognostic biomarkers, among which lncRNA HAGLROS was one of the lncRNA significantly upregulated in breast cancer tissues (Fig. 1A, B). The gene discussed is HAGLROS; the disease is breast carcinoma.